畜牧兽医学报 ›› 2011, Vol. 42 ›› Issue (4): 544-550.doi:

• 预防兽医 • 上一篇    下一篇

禽波氏杆菌外膜蛋白A的克隆测序与生物信息分析

谭燕玲,朱瑞良*,王慧,王新建,魏凯,孙振红,盛鹏程   

  1. 山东农业大学动物科技学院,山东省动物生物技术与疫病防治重点实验室,泰安271018
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2011-04-20 发布日期:2011-04-20
  • 通讯作者: 朱瑞良

Cloning, Sequencing, Secondary Structure and B-cell Epitopes Prediction of Bordetella avium Outer Membrane Protein OmpA

TAN Yan-ling, ZHU Rui-liang*, WANG Hui, WANG Xin-jian,WEI Kai,SUN Zhen-hong, SHENG Peng-cheng   

  1. Shandong Provincial Key Laboratory of Animal Biotechnology and Disease Control and Prevention, College of Animal Science and Technology, Shandong Agricultural University, Tai′ an 271018; China
  • Received:1900-01-01 Revised:1900-01-01 Online:2011-04-20 Published:2011-04-20

摘要: 本文旨在克隆禽波氏杆菌外膜蛋白OmpA的编码基因,并预测OmpA蛋白二级结构和B细胞抗原表位,从而探讨禽波氏杆菌外膜蛋白OmpA在免疫保护中所起的作用。作者对禽波氏杆菌的外膜蛋白ompA基因进行PCR扩增、克隆及序列测定。应用生物信息学相关软件和方法,对禽波氏杆菌OmpA蛋白的二级结构和B细胞抗原表位进行预测。禽波氏杆菌ompA基因全长597 bp,编码199个氨基酸。二级结构以无规卷曲为主,有少量的α-螺旋和β-片层,少见β-转角;推测OmpA蛋白有5个B细胞优势抗原表位区域、2个糖基化位点。本研究为进一步分析禽波氏杆菌免疫机理、制备单克隆抗体和设计表位疫苗等奠定理论基础。

Abstract: The aims of this study was to clone and sequence the ompA gene of Bordetella avium, and predict its secondary structure and B-cell epitopes, which provides a theoretical basis for the study of immune mechanism and B. avium subunit vaccine. The B. avium ompA gene was amplified, cloned, and sequenced. By using bioinformatics softwares and methods, the secondary structure and B-cell preponderant epitope of B. avium OmpA were predicted The results indicated that B. avium ompA gene is 597 bp, encoding 199 amino acids. Using three methods, prediction of the secondary structure of B. avium OmpA indicated that random coils were the main structural type of the flexible region in secondary structure, and contain a small amount of α-helix, β-sheet and a rare β-turn. The OmpA protein was supposed contain 5 potential antigen epitopes and 2 potential glycosylated sites. These results provide a theoretical basis for the further study of immune mechanisms, monoclonal antibodies preparation and epitope vaccine design.